Sun Elaine D Insider Trades

Insider Trading History

Track insider trading activity for Sun Elaine D. See latest buy and sell transactions across all companies.

Holdings

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price

Insider Trades History

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price
Recursion Pharmaceuticals
Recursion Pharmaceuticals RXRX
Director
Holding Value $450k 135,981 shares
Last Trade
Jun 17, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$291k 88,424 shares
$3.29
$3.31
Dynavax Technologies
Dynavax Technologies DVAX
Director
Holding Value $0 0 shares
Last Trade
Feb 10, 2026 Sale (Sale to Issuer)Shares sold back to the company, such as a repurchase or tender.
$2.47M 159,615 shares
$15.50
$15.50
Recursion Pharmaceuticals
Recursion Pharmaceuticals RXRX
Director
Holding Value $157k 47,557 shares
Last Trade
Jun 18, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$113k 22,016 shares
$5.11
$3.31
Dynavax Technologies
Dynavax Technologies DVAX
Director
Holding Value $463k 29,865 shares
Last Trade
Jun 11, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$290k 28,500 shares
$10.18
$15.50
Recursion Pharmaceuticals
Recursion Pharmaceuticals RXRX
Director
Holding Value $242k 73,099 shares
Last Trade
Mar 17, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$500k 73,099 shares
$6.84
$3.31
Dynavax Technologies
Dynavax Technologies DVAX
Director
Holding Value $374k 24,107 shares
Last Trade
May 23, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$267k 22,500 shares
$11.85
$15.50
Dynavax Technologies
Dynavax Technologies DVAX
Director
Holding Value $349k 22,500 shares
Last Trade
May 26, 2023 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$312k 27,857 shares
$11.20
$15.50
Dynavax Technologies
Dynavax Technologies DVAX
Director
Holding Value $174k 11,250 shares
Last Trade
May 26, 2022 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$294k 25,179 shares
$11.68
$15.50
Dynavax Technologies
Dynavax Technologies DVAX
Director
Holding Value $698k 45,000 shares
Last Trade
Dec 10, 2021 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$743k 55,714 shares
$13.33
$15.50
Halozyme Therapeutics
Halozyme Therapeutics HALO
Svp, Chief Financial Officer
Holding Value $1.37M 18,077 shares
Last Trade
Apr 01, 2021 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$433k 10,196 shares
$42.43
$75.82
Halozyme Therapeutics
Halozyme Therapeutics HALO
Svp, Chief Financial Officer
Holding Value $1.06M 14,018 shares
Last Trade
Apr 01, 2021 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$172k 4,059 shares
$42.43
$75.82
Halozyme Therapeutics
Halozyme Therapeutics HALO
Svp, Chief Financial Officer
Holding Value $2.32M 30,600 shares
Last Trade
Apr 01, 2021 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$433k 10,196 shares
$42.43
$75.82
Halozyme Therapeutics
Halozyme Therapeutics HALO
Svp, Chief Financial Officer
Holding Value $598k 7,881 shares
Last Trade
Mar 02, 2021 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$193k 4,285 shares
$45.01
$75.82
Halozyme Therapeutics
Halozyme Therapeutics HALO
Svp, Chief Financial Officer
Holding Value $922k 12,166 shares
Last Trade
Mar 02, 2021 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$548k 12,166 shares
$45.01
$75.82
Halozyme Therapeutics
Halozyme Therapeutics HALO
Svp, Chief Financial Officer
Holding Value $2.77M 36,496 shares
Last Trade
Mar 02, 2021 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$548k 12,166 shares
$45.01
$75.82
Halozyme Therapeutics
Halozyme Therapeutics HALO
Svp, Chief Financial Officer
Holding Value $1.94M 25,642 shares
Last Trade
Feb 15, 2021 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$1.28M 25,642 shares
$49.84
$75.82
Halozyme Therapeutics
Halozyme Therapeutics HALO
Svp, Chief Financial Officer
Holding Value $3.09M 40,796 shares
Last Trade
Apr 01, 2020 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$666k 40,796 shares
$16.32
$75.82
Halozyme Therapeutics
Halozyme Therapeutics HALO
Svp, Chief Financial Officer
Holding Value $7.96M 104,969 shares
Last Trade
Mar 02, 2020 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$3.16M 153,631 shares
$20.55
$75.82

See more insider trades for free

Join Stockcircle to see more insider trades and be the first to know about new executive transactions.

Sign Up